VRAS (Velys Robot-Assisted Solution) Operational Excellence Study
Condition(s) studied
Investigational drug(s) / intervention(s)
Robotic-assisted TKA: Robotic-assisted Total Knee Arthroplasty or total knee replacement is a surgical procedure using a robot to resurface a knee joint damaged with arthritis, and where the knee joint of the patient is replaced with a prosthesis.
Conventional TKA: Conventional Total Knee Arthroplasty or total knee replacement is a surgical procedure to manually resurface a knee joint damaged with arthritis, and where the knee joint of the patient is replaced with a prosthesis.
Study summary
The aim of this study is to investigate the differences in process set-up, efficiency, OR team workload, instrument trays and OR financial performance when using the VRAS (Velys Robotic Assisted Solution) of DePuy Synthes compared to conventional TKA.
Eligibility
Primary outcome measure(s)
- Operational efficiency — 3 months
Efficiency will be assessed using OR time, by comparing the OR days and procedures where TKR is performed conventionally or by using VRAS surgery. A granular analysis from the timestamps will be conducted using standard descriptive statistics. Additionally, the impaction process will be further analyzed, broken down into parts.
Trial sites (10)
| Facility | City | Region | Status |
|---|---|---|---|
| Herz-Jesu Krankenhaus | Vienna | Austria | |
| Orthopädisches Spital Speising | Vienna | Austria | |
| AZ Sint-Jan Brugge | Bruges | Belgium | |
| Hôpital de la Croix Saint-Simon | Paris | France | |
| Kliniken Hochfranken | Münchberg | Germany | |
| Clinica Nuova Itor | Roma | Italy | |
| Hospital General Universitario Gregorio Marañón | Madrid | Spain | |
| Schulthess Klinik | Zurich | Switzerland | |
| Leeds Teaching Hospitals NHS Trust | Leeds | United Kingdom | |
| Liverpool University Hospitals NHS Foundation Trust - Broadgreen Hospital | Liverpool | United Kingdom |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06563843 on ClinicalTrials.gov ↗ ← All trials in the UK